Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06517641 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

Study acronym: BMT CTN CureAA
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 2 of 25 sitesv5
  2. Site details revised at 3 of 25 sitesv4
  3. Study sites: 22 to 25 Start date changed from estimate of May 31, 2025 to May 12, 2025v3 Show 1 more changeShow less
    • Start date changed from estimate of May 31, 2025 to May 12, 2025
  4. Trial status: Not Yet Recruiting to Recruiting Start date: Sep 1, 2024 to May 31, 2025 · Study sites: 10 to 22 · Secondary endpoints: details revised at 1 of 12 entriesv2 Show 3 more changesShow less
    • Start date: Sep 1, 2024 to May 31, 2025
    • Study sites: 10 to 22
    • Secondary endpoints: details revised at 1 of 12 entries
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated.
Trial Details
NCT Number NCT06517641
Lead Sponsor Medical College of Wisconsin
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), Sanofi
Conditions Severe Aplastic Anemia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov